Dr Chelsey Smith from Cedars-Sinai Medical Center talks about autoimmune disease outcomes in pregnancies exposed to anakinra before, during, and after birth.

Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: CV biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on CV events.

Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: CV biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on CV events.

Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: CV biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on CV events.

Albert Rizzo, MD, talks about pulmonary fibrosis, how it is diagnosed and treated, and the future of pulmonary fibrosis treatments.

Albert Rizzo, MD, talks about pulmonary fibrosis, how it is diagnosed and treated, and the future of pulmonary fibrosis treatments.

Albert Rizzo, MD, talks about pulmonary fibrosis, how it is diagnosed and treated, and the future of pulmonary fibrosis treatments.

Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.

Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.

Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.